Mammary Cell News Volume 16.01 | Jan 11 2024

    0
    11







    2024-01-11 | MCN 16.02


    Mammary Cell News by STEMCELL Technologies
    Vol. 16.01 – 11 January, 2024
    TOP STORY

    Vertical Pathway Inhibition of Receptor Tyrosine Kinases and BAD with Synergistic Efficacy in Triple Negative Breast Cancer

    NCK promoted apoptosis and G0/G1 cell cycle arrest of TNBC cell lines in vitro, concordant with gene expression analyses, and reduced in vivo xenograft growth and metastatic burden, demonstrating efficacy as a single agent.
    [NPJ Precision Oncology]

    Full Article
    Tips to prepare for your next conference or networking event
    PUBLICATIONSRanked by the impact factor of the journal

    DMT1-Dependent Endosome-Mitochondria Interactions Regulate Mitochondrial Iron Translocation and Metastatic Outgrowth

    Investigators showed that Divalent Metal Transporter 1 (DMT1) sustained mitochondrial iron translocation via early endosome-mitochondria interactions in triple-negative MDA-MB-231, but not in luminal A T47D breast cancer cells.
    [Oncogene]

    Full ArticleGraphical Abstract

    Stabilization of Epithelial β-Catenin Compromises Mammary Cell Fate Acquisition and Branching Morphogenesis

    Investigators reported a strong downregulation of epithelial Wnt/β-catenin activity as the mammary bud progresses to branching. They showed that forced activation of epithelial β-catenin severely compromised embryonic mammary gland branching.
    [Journal Of Investigative Dermatology]

    Full Article

    ZO-1 Regulates the Migration of Mesenchymal Stem Cells in Cooperation with α-Catenin in Response to Breast Tumor Cells

    Scientists identified zonula occludens-1 (ZO-1) as a specific intrinsic molecule that played a vital role in mediating the collective migration of mesenchymal stem cells towards breast tumor cells and transforming growth factor beta, which was a crucial factor secreted by breast tumor cells.
    [Cell Death Discovery]

    Full Article

    Fatty Acid Amide Hydrolase Drives Adult Mammary Gland Development by Promoting Luminal Cell Differentiation

    Researchers reported that the endocannabinoid-degrading enzyme fatty acid amide hydrolase played a pivotal role in adult mammary gland development.
    [Cell Death Discovery]

    Full Article

    The Combination of IDO and AHR Blockers Reduces the Migration and Clonogenicity of Breast Cancer Cells

    Investigators evaluated the role of the indoleamine-2,3-dioxygenase (IDO) and aryl hydrocarbon receptor (AHR) blockers on cell migration, clonogenic, and IDO expression of murine breast cancer cells. The cell migration and clonogenic abilities of breast cancer cells were evaluated.
    [Immunologic Research]

    Abstract

    Tumor-Specific Hybrid Nanoparticles in Therapy of Breast Cancer

    Salicylic acid was dopped into poly(3-hydroxybutyrate) and prepared nanoparticles to increase encapsulation efficiency, anti-cancer activity of caffeic acid, and folic acid for breast cancer treatment.
    [Journal Of Microencapsulation]

    Abstract

    Doxorubicin-Sanguinarine Nanoparticles: Formulation and Evaluation of Breast Cancer Cell Apoptosis and Cell Cycle

    Sanguinarine, HPMC-NPs, and doxorubicin were tested on Adriamycin-resistant MCF-7/ADR breast cancer cells, parent-sensitive MCF-7, and MCR-5 normal cells
    [Drug Development And Industrial Pharmacy]

    AbstractGraphical Abstract

    Knockout of KDM3A in MDA-MB-231 Breast Cancer Cells Inhibits Tumor Malignancy and Promotes Apoptosis

    Scientists investigated the effect of histone lysine demethylase 3 A (KDM3A) expression with TNBC invasion and metastasis. In our results, knockout of KDM3A in TNBC MDA-MB-231 cells promoted apoptosis and inhibited the proliferation, invasion, and metastasis of MDA-MB-231 cells.
    [Journal Of Molecular Histology]

    Full Article
    Request a free copy of this wallchart for a quick reference on breast cancer subtypes and signaling pathways.
    REVIEWS

    Management of Patients with Advanced-Stage HER2-Positive Breast Cancer: Current Evidence and Future Perspectives

    Scientists described key steps in the development of the modern paradigm for the treatment of HER2-positive advanced-stage breast cancer, including selecting and sequencing new-generation HER2-targeted therapies, and summarize efficacy and safety outcomes from pivotal studies.
    [Nature Reviews Clinical Oncology]

    Abstract

    LCN2: Versatile Players in Breast Cancer

    The authors provide an in-depth review of the advancement of Lipocalin 2 (LCN2) in the context of breast cancer occurrence and development.
    [Biomedicine & Pharmacotherapy]

    Full ArticleGraphical Abstract
    INDUSTRY AND POLICY NEWS

    Prevent Cancer Foundation Awards $380,000 in Global Innovation Grants

    “From training Zambia’s first breast radiologists and testing AI-supported breast cancer diagnosis in Nigeria to implementing novel approaches for addressing cervical cancer in Cameroon and Mexico, the Prevent Cancer Foundation is proud to support the 2024 Global Innovation Grants,” said CEO Jody Hoyos.
    [Prevent Cancer Foundation]

    Press Release
    FEATURED EVENT

    2024 ACS Cancer Conference

    February 22 – 24, 2024
    Austin, Texas, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Research Associate – Morphogenesis of the Lung and Mammary Gland

    Princeton University – Princeton, New Jersey, United States

    Postdoctoral Researcher – Computational Cancer Evolution

    Human Technopole – Milan, Italy

    Research Fellow – Breast and Lung Cancer Diagnosis

    University of Melbourne – Melbourne, Australia

    PhD Positions – Cancer Cell Signaling

    Zhejiang Chinese Medical University – Hangzhou, China

    Animal Technician – Experimental Therapeutics

    BC Cancer – Vancouver, British Columbia, Canada

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2